Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
35.8M
-
Shares change
-
+134K
-
Total reported value, excl. options
-
$293M
-
Value change
-
-$8.67M
-
Put/Call ratio
-
0.62
-
Number of buys
-
56
-
Number of sells
-
-28
-
Price
-
$8.20
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q4 2017
124 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q4 2017.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.8M shares
of 157M outstanding shares and own 22.74% of the company stock.
Largest 10 shareholders include FMR LLC (4.95M shares), BRIDGER MANAGEMENT, LLC (4.39M shares), BlackRock Inc. (3.41M shares), STATE STREET CORP (3.41M shares), venBio Select Advisor LLC (3.29M shares), FRANKLIN RESOURCES INC (2.46M shares), Vanguard Group Inc (2.43M shares), SENZAR ASSET MANAGEMENT, LLC (1.36M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.07M shares), and NORTHERN TRUST CORP (618K shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.